uniQure is a Netherlands-based biotechnology company developing gene therapies for serious genetic diseases such as hemophilia and Huntington's disease.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 76 | New buy | 606,212 | $27,922,125 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Added +170% | 1,081,189 | $49,799,565 | 0.1% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.